Study of targeted treatment for Parkinson's disease symptoms
Part of Brain & nervous system clinical trials.
This study compares different ways of targeting treatment for Parkinson's disease symptoms. It is designed for people with mild to moderate Parkinson's who have had symptoms for at least 2 years and are generally stable on their current medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older.
- You have been diagnosed with Parkinson's disease, and your symptoms started when you were 40 or older.
- Your symptoms improve with dopamine replacement therapy (like levodopa).
- Your Parkinson's is at a mild-to-moderate stage (Hoehn and Yahr stage 1.5 to 2.5).
- You can walk independently for at least 5 minutes without help, and you do not have severe freezing of gait.
- You have been on the same Parkinson's medication for at least 4 weeks before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different schedules of a non-invasive brain stimulation treatment (called tTIS) to standard medication for Parkinson's disease. It aims to find the best timing for tTIS to improve motor symptoms.
This study tests a new, non-invasive brain stimulation method called Temporal Interference Stimulation (TIS) to see if it can improve walking and other symptoms in people with Parkinson's disease. It's for people who are in early-to-mid stages and can walk independently.
This trial tests a non-invasive brain stimulation technique, called temporal interference stimulation, that aims to improve movement and non-movement symptoms in people with Parkinson's disease. If you have had Parkinson's for at least a year and are on stable medication, you might qualify.
This study tests a new, noninvasive brain stimulation technique (called temporal interference stimulation) given at different frequencies. It aims to improve Parkinson's symptoms by gently stimulating the brain area involved in movement.
This trial compares two brain targets for deep brain stimulation (DBS), a surgery that uses implanted electrodes to help control Parkinson's symptoms. It aims to see which target works better for people whose symptoms are not well controlled by medication.
This study looks at how people with Parkinson’s adapt their movements and how their brain sensorimotor system works. It may help researchers improve understanding of Parkinson’s and refine movement-focused therapies.
Hear when a new PARKINSON DIS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.